Study of Lymphatic Dysfunction in Primary and Secondary Lymphedema

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Lymphedema is a disorder of the lymphatic vascular system characterized by impaired lymphatic return and swelling of the extremities and accumulation of undrained interstitial fluid/lymph that results in fibrosis and adipose tissue deposition in the affected area. It can be an inherited condition (primary lymphedema) or occurs after cancer surgery and lymph node removal (secondary lymphedema). It causes a significant morbidity and is a common disabling disease affecting more than 200 million people worldwide, however there is no curative treatment for primary or secondary lymphedema.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: f
View:

• Patients in who developed primary lymphedema or secondary lymphedema after breast cancer treatment.

• Male and female over the age of 18 and under 75.

• Patient affiliated to a social security scheme in France.

• Patient having signed informed consent prior to inclusion in the study and prior to any specific procedure for the study.

• Patients with no recidive \> 3 years after cancer surgery.

• Patients with Body Mass Index \<35.

• Patient enrolled in a care pathway for the management of their lymphedema (medical and educational care).

• Patients wearing a compression orthosis on the limb with lymphedema.

Locations
Other Locations
France
Toulouse Hospital
RECRUITING
Toulouse
Contact Information
Primary
Julie MALLOIZEL-DELAUNAY, MD
malloizel-delaunay.j@chu-toulouse.fr
+33 (0)5 61 32 30 33
Backup
Charline DAGUZAN
daguzan.c@chu-toulouse.fr
+33 (0)5 61 77 84 99
Time Frame
Start Date: 2024-02-21
Estimated Completion Date: 2026-02
Participants
Target number of participants: 60
Treatments
Experimental: primary lymphoedema
patients with primary lymphoedema
Experimental: secondary lymphoedema
patients with secondary lymphoedema
Related Therapeutic Areas
Sponsors
Leads: University Hospital, Toulouse

This content was sourced from clinicaltrials.gov